Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Spatial distribution of positive cores improves the selection of patients with low-risk prostate cancer as candidates for active surveillance.

Abdollah F, Suardi N, Capitanio U, Gallina A, Sun M, Villa L, Scattoni V, Bianchi M, Tutolo M, Fossati N, Karakiewicz P, Rigatti P, Montorsi F, Briganti A.

BJU Int. 2013 Aug;112(4):E234-42. doi: 10.1111/bju.12152. Epub 2013 Jun 7.

2.

Magnetic resonance imaging does not improve the prediction of misclassification of prostate cancer patients eligible for active surveillance when the most stringent selection criteria are based on the saturation biopsy scheme.

Ploussard G, Xylinas E, Durand X, Ouzaïd I, Allory Y, Bouanane M, Abbou CC, Salomon L, de la Taille A.

BJU Int. 2011 Aug;108(4):513-7. doi: 10.1111/j.1464-410X.2010.09974.x. Epub 2010 Dec 22.

3.

Analysis of outcomes after radical prostatectomy in patients eligible for active surveillance (PRIAS).

El Hajj A, Ploussard G, de la Taille A, Allory Y, Vordos D, Hoznek A, Abbou CC, Salomon L.

BJU Int. 2013 Jan;111(1):53-9. doi: 10.1111/j.1464-410X.2012.11276.x. Epub 2012 Jun 21.

4.

Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.

Gallina A, Maccagnano C, Suardi N, Capitanio U, Abdollah F, Raber M, Salonia A, Scattoni V, Rigatti P, Montorsi F, Briganti A.

BJU Int. 2012 Jul;110(2 Pt 2):E64-8. doi: 10.1111/j.1464-410X.2011.10762.x. Epub 2011 Nov 17.

5.

The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.

Corcoran NM, Casey RG, Hong MK, Pedersen J, Connolly S, Peters J, Harewood L, Gleave ME, Costello AJ, Hovens CM, Goldenberg SL.

BJU Int. 2012 Jul;110(1):36-42. doi: 10.1111/j.1464-410X.2011.10681.x. Epub 2011 Nov 15.

6.

Pathologic prostate cancer characteristics in patients eligible for active surveillance: a head-to-head comparison of contemporary protocols.

Iremashvili V, Pelaez L, Manoharan M, Jorda M, Rosenberg DL, Soloway MS.

Eur Urol. 2012 Sep;62(3):462-8. doi: 10.1016/j.eururo.2012.03.011. Epub 2012 Mar 17.

PMID:
22445138
7.

Comprehensive report on prostate cancer misclassification by 16 currently used low-risk and active surveillance criteria.

Palisaar JR, Noldus J, Löppenberg B, von Bodman C, Sommerer F, Eggert T.

BJU Int. 2012 Sep;110(6 Pt B):E172-81. doi: 10.1111/j.1464-410X.2012.10935.x. Epub 2012 Feb 7.

8.

Patient selection and pathological outcomes using currently available active surveillance criteria.

El Hajj A, Ploussard G, de la Taille A, Allory Y, Vordos D, Hoznek A, Abbou CC, Salomon L.

BJU Int. 2013 Aug;112(4):471-7. doi: 10.1111/bju.12154. Epub 2013 Jun 7.

9.

Expanded criteria to identify men eligible for active surveillance of low risk prostate cancer at Johns Hopkins: a preliminary analysis.

Reese AC, Landis P, Han M, Epstein JI, Carter HB.

J Urol. 2013 Dec;190(6):2033-8. doi: 10.1016/j.juro.2013.05.015. Epub 2013 May 13.

PMID:
23680308
10.

Biopsy features associated with prostate cancer progression in active surveillance patients: comparison of three statistical models.

Iremashvili V, Manoharan M, Rosenberg DL, Soloway MS.

BJU Int. 2013 Apr;111(4):574-9. doi: 10.1111/j.1464-410X.2012.11127.x. Epub 2012 May 4.

11.

Pathological and biochemical outcomes after radical prostatectomy in men with low-risk prostate cancer meeting the Prostate Cancer International: Active Surveillance criteria.

Mitsuzuka K, Narita S, Koie T, Kaiho Y, Tsuchiya N, Yoneyama T, Kakoi N, Kawamura S, Tochigi T, Habuchi T, Ohyama C, Arai Y.

BJU Int. 2013 May;111(6):914-20. doi: 10.1111/j.1464-410X.2012.11658.x. Epub 2013 Jan 15.

13.

Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer.

Capitanio U, Karakiewicz PI, Valiquette L, Perrotte P, Jeldres C, Briganti A, Gallina A, Suardi N, Cestari A, Guazzoni G, Salonia A, Montorsi F.

Urology. 2009 May;73(5):1087-91. doi: 10.1016/j.urology.2008.10.048. Epub 2009 Feb 4.

PMID:
19195695
14.

The relationship between Prostate CAncer gene 3 (PCA3) and prostate cancer significance.

van Poppel H, Haese A, Graefen M, de la Taille A, Irani J, de Reijke T, Remzi M, Marberger M.

BJU Int. 2012 Feb;109(3):360-6. doi: 10.1111/j.1464-410X.2011.10377.x. Epub 2011 Aug 26.

15.
16.

Active surveillance: patient selection.

Klotz L.

Curr Opin Urol. 2013 May;23(3):239-44. doi: 10.1097/MOU.0b013e32835f8f6b. Review.

PMID:
23548978
17.

Association of prostate cancer risk alleles with unfavourable pathological characteristics in potential candidates for active surveillance.

McGuire BB, Helfand BT, Kundu S, Hu Q, Banks JA, Cooper P, Catalona WJ.

BJU Int. 2012 Aug;110(3):338-43. doi: 10.1111/j.1464-410X.2011.10750.x. Epub 2011 Nov 11.

18.

Radical prostatectomy for low-risk prostate cancer following initial active surveillance: results from a prospective observational study.

Bul M, Zhu X, Rannikko A, Staerman F, Valdagni R, Pickles T, Bangma CH, Roobol MJ.

Eur Urol. 2012 Aug;62(2):195-200. doi: 10.1016/j.eururo.2012.02.002. Epub 2012 Feb 14.

PMID:
22342775
19.

Age-adjusted validation of the most stringent criteria for active surveillance in low-risk prostate cancer patients.

Suardi N, Gallina A, Capitanio U, Salonia A, Lughezzani G, Freschi M, Mottrie A, Rigatti P, Montorsi F, Briganti A.

Cancer. 2012 Feb 15;118(4):973-80. doi: 10.1002/cncr.26234. Epub 2011 Jul 12. Erratum in: Cancer. 2012 May 1;118(9):2560.

20.

Testing the most stringent criteria for selection of candidates for active surveillance in patients with low-risk prostate cancer.

Suardi N, Briganti A, Gallina A, Salonia A, Karakiewicz PI, Capitanio U, Freschi M, Cestari A, Guazzoni G, Rigatti P, Montorsi F.

BJU Int. 2010 Jun;105(11):1548-52. doi: 10.1111/j.1464-410X.2009.09057.x. Epub 2009 Nov 13.

Supplemental Content

Support Center